icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
A5327 Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1-infected Individuals (SWIFT-C)
 
 
  Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
 
Susanna Naggie1, Daniel S. Fierer2, Michael Hughes3, Arthur Kim4, Annie Leutkemeyer5, Vincent Vu3, Jhoanna Roa3, Steve Rwema4, Diana M. Brainard6, John G. McHutchison6, Marion G. Peters5, Jennifer J. Kiser7, Kristen M. Marks8, Raymond Chung4 for the AIDS Clinical Trials Group (ACTG) A5327 Study Team
1Duke University Medical Center, Durham, NC, United States, 2Mount Sinai School of Medicine, New York, NY, United States, 3Harvard, Cambridge, MA, United States, 4Massachusetts General Hospital, Boston, MA, United States, 5University of California, San Francisco, San Francisco, CA, United States, 6Gilead Sciences, Inc, Foster City, CA, United States, 7University of Colorado, Denver, CO, United States, 8Weill Cornell, New York, NY, United States

1024171

1024172

1024173

1024174

1024175

1024176

1024177